Animal Health International Inc., a Westlake, Texas-based distributor of animal health products, has set its proposed IPO terms to 11.8 million common shares being offered at between $10 and $12 per share. It plans to trade on the Nasdaq under ticker symbol AHII, with JPMorgan serving as lead underwriter. Charlesbank Capital Partners bought the company from Bain Capital in 2005, and holds a 76.4% pre-IPO position.
Harbin Pharmaceutical Group Co. said that it is considering an overseas IPO. The Chinese drug-maker already is listed in Shanghai, and is controlled by a consortium led by Warburg Pincus.
Monotype Imaging Holdings Inc., a Woburn, Mass.-based provider of text imaging software, has filed for a $135 million IPO. It plans to trade on the Nasdaq under ticker symbol TYPE, with Banc of America Securities serving as lead underwriter. TA Associates holds an 81.2% pre-IPO ownership position, with D.B. Zwirn holding a 3.9% stake.
Validus Holdings Ltd., a Bermuda-based reinsurance company, has filed for a $200 million IPO. It plans to trade on the NYSE under ticker symbol VR, with Goldman Sachs and Merrill Lynch serving as co-lead underwriters. Validus was formed in October 2005, with funding from Aquiline Capital Partners, Goldman Sachs Capital Partners, Vestar Capital Partners, New Mountain Capital and Merrill Lynch Global Private Equity.